Validation of a locked nucleic acid based wild-type blocking PCR for the detection of EGFR exon 18/19 mutationsLiesbet Vliegen, Peter Vandenberghe(KU Leuven)Diagnostic PathologyMay 28, 201510.1186/s13000-015-0293-1Cited by 7SaveCiteExport RISWatch citationsRelated PapersThe kinase inhibitor TKI258 is active against the novel CUX1-FGFR1 fusion detected in a patient with T-lymphoblastic leukemia/lymphoma and t(7;8)(q22;p11)|Haematologica|2011|61